Cargando…
Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein
Kallikrein-related peptidase 6 (KLK6) overexpression is commonly observed in primary tumors of colorectal cancer (CRC) patients and has been associated with tumor aggressiveness, metastasis, and poor prognosis. We previously established a unique contribution of KLK6 in colon cancer metastasis via a...
Autores principales: | Chen, Hwudaurw, Sells, Earlphia, Pandey, Ritu, Abril, Edward R., Hsu, Chiu-Hsieh, Krouse, Robert S., Nagle, Raymond B., Pampalakis, Georgios, Sotiropoulou, Georgia, Ignatenko, Natalia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817440/ https://www.ncbi.nlm.nih.gov/pubmed/31692974 http://dx.doi.org/10.18632/oncotarget.27153 |
Ejemplares similares
-
Specific microRNA–mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein–Related Peptidase 6()
por: Sells, Earlphia, et al.
Publicado: (2017) -
Evolutionary History of Tissue Kallikreins
por: Pavlopoulou, Athanasia, et al.
Publicado: (2010) -
Kallikreins emerge as new regulators of viral infections
por: Pampalakis, Georgios, et al.
Publicado: (2021) -
Novel specific activity-based probes validate KLK proteases as druggable targets
por: Sotiropoulou, Georgia, et al.
Publicado: (2022) -
Activity-Based Probes for Proteases Pave the Way to Theranostic Applications
por: Sotiropoulou, Georgia, et al.
Publicado: (2022)